APO LE 20 (Leflunomide 20 mg)
Pill imprint APO LE 20 has been identified as Leflunomide 20 mg.
Leflunomide is used in the treatment of rheumatoid arthritis; psoriatic arthritis and belongs to the drug classes antirheumatics, selective immunosuppressants. Not for use in pregnancy. Leflunomide 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- APO LE 20
- Strength:
- 20 mg
- Color:
- White
- Shape:
- Three-sided
- Availability:
- Prescription only
- Drug Class:
- Antirheumatics
Selective immunosuppressants - Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-2503
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
crospovidone
magnesium stearate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 60429-0320 | Golden State Medical Supply (repackager) |
Note: Inactive ingredients may vary.
More about leflunomide
Consumer resources
- Other brands: Arava
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
